OTC Pharmaceuticals - Australia

  • Australia
  • Revenue in the OTC Pharmaceuticals market amounts to €4,215.00m in 2024. The market is expected to grow annually by 5.76% (CAGR 2024-2029).
  • The market's largest segment is the segment Vitamins & Minerals with a market volume of €1,300.00m in 2024.
  • In global comparison, most revenue is generated in the United States (€38,250m in 2024).
  • In relation to total population figures, per person revenues of €157.90 are generated in 2024.
  • In the OTC Pharmaceuticals market, 23.5% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

Comparación de regiones

Analyst Opinion

The OTC Pharmaceuticals market in Australia has been experiencing significant growth in recent years. Customer preferences have shifted towards self-medication and a preference for over-the-counter products, driving the demand for OTC Pharmaceuticals. This trend is expected to continue due to several factors, including increasing healthcare costs, changing demographics, and a growing focus on preventive healthcare.

Customer preferences:
Customers in Australia are increasingly turning to self-medication as a way to manage minor health issues. This is driven by the convenience and accessibility of over-the-counter products, which can be purchased without a prescription. Additionally, there is a growing preference for natural and alternative remedies, leading to an increase in demand for herbal and homeopathic OTC products.

Trends in the market:
One major trend in the OTC Pharmaceuticals market in Australia is the growing demand for preventive healthcare products. As consumers become more health-conscious, they are seeking out products that can help them maintain their well-being and prevent illnesses. This has led to an increase in sales of vitamins, supplements, and other preventive healthcare products. Another trend in the market is the increasing availability of OTC Pharmaceuticals in non-traditional retail channels. Pharmacies and supermarkets have traditionally been the main distribution channels for OTC products, but there has been a rise in online sales and the availability of OTC products in convenience stores and other non-pharmacy outlets. This has made it easier for consumers to access OTC products and has contributed to the overall growth of the market.

Local special circumstances:
Australia has a well-developed healthcare system, which includes a strong pharmaceutical industry and a robust regulatory framework. The Therapeutic Goods Administration (TGA) regulates the sale and marketing of OTC Pharmaceuticals in Australia, ensuring that products are safe and effective. This provides consumers with confidence in the quality of OTC products available in the market. Additionally, Australia has a high level of health literacy among its population. Consumers are well-informed about their health and are actively seeking out information on self-medication and OTC products. This has contributed to the growth of the OTC Pharmaceuticals market, as consumers are more willing to take responsibility for their own health and make informed decisions about their healthcare needs.

Underlying macroeconomic factors:
The growth of the OTC Pharmaceuticals market in Australia is also influenced by underlying macroeconomic factors. Australia has a strong economy with a high level of disposable income, allowing consumers to spend more on healthcare products. Additionally, the aging population in Australia is driving the demand for OTC products, as older adults are more likely to experience chronic health conditions and require ongoing self-medication. In conclusion, the OTC Pharmaceuticals market in Australia is experiencing significant growth due to customer preferences for self-medication, a focus on preventive healthcare, and the availability of OTC products in non-traditional retail channels. The local special circumstances, including a well-developed healthcare system and high health literacy, contribute to the growth of the market. Underlying macroeconomic factors, such as a strong economy and an aging population, also play a role in driving the demand for OTC Pharmaceuticals in Australia.


Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.


In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Visión general

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Espere, por favor


¿Alguna duda? Estaremos encantados de atenderte.
Statista Locations
Contacto Nerea Marcos
Nerea Marcos
Client Success Manager

Lu - vi, 9:30 - 17:00 h (CET)

Contacto Meredith Alda
Meredith Alda
Sales Manager– Contacto (Estados Unidos)

Lu - vi, 9:00 - 18:00 h (EST)

Contacto Yolanda Mega
Yolanda Mega
Operations Manager– Contacto (Asia)

Lu - vi, 9:00 - 17:00 h (SGT)

Contacto Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contacto (Asia)

Lu - vi, 10:00 - 18:00 h (JST)

Contacto Lodovica Biagi
Lodovica Biagi
Director of Operations– Contacto (Europa)

Lu - vi, 9:30 - 17:00 h (GMT)

Contacto Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contacto (América Latina)

Lu - vi, 9:00am-6:00pm (EST)